|
Re: ... removed posts????
|
5
|
Resverlogix Corp.
|
Oct 30, 2017 01:37PM
|
|
Epigenetic Primer
|
5
|
Resverlogix Corp.
|
Jul 19, 2018 03:36PM
|
|
Re: Reply from Sarah
|
5
|
Zenith Epigenetics
|
Dec 11, 2015 06:20PM
|
|
Re: So.....?
|
5
|
Resverlogix Corp.
|
Oct 14, 2017 04:08PM
|
|
Re: Potential funding for BETONMACE2 and Covid trial
|
5
|
Resverlogix Corp.
|
Oct 25, 2021 07:30PM
|
|
Re: How is Zenith affected by the RVX top line miss
|
5
|
Zenith Epigenetics
|
Oct 02, 2019 08:43AM
|
|
Re: Good news thoughts
|
5
|
Resverlogix Corp.
|
Jan 18, 2022 12:47PM
|
|
Re: AGM Sept. 12, 2018
|
5
|
Resverlogix Corp.
|
Jun 30, 2018 12:10PM
|
|
Re: ... keeping it simple...
|
5
|
Resverlogix Corp.
|
Nov 06, 2017 11:46AM
|
|
Re: Institutional Investors
|
5
|
Resverlogix Corp.
|
Dec 13, 2020 06:41PM
|
|
Re: Concerns Mount Over COVID-19 'Rebounds' After Treatment With Pfizer's Paxlovid
|
5
|
Resverlogix Corp.
|
Jun 02, 2022 02:44PM
|
|
Re: Happy New Years
|
5
|
Resverlogix Corp.
|
Dec 31, 2023 01:33PM
|
|
Re: No news, did you expect a change
|
5
|
Resverlogix Corp.
|
Sep 22, 2022 04:46PM
|
|
Momentum
|
5
|
Resverlogix Corp.
|
Jul 30, 2018 05:16PM
|
|
Re: Consequences of BETonMACE Findings
|
5
|
Resverlogix Corp.
|
May 11, 2016 03:50PM
|
|
Re: The Biotech Blindspot
|
5
|
Resverlogix Corp.
|
Jul 04, 2020 07:08PM
|
|
Re: Trial Status
|
5
|
Resverlogix Corp.
|
Jul 21, 2021 08:14PM
|
|
Re: Cases of COVID-19 infection are on the rise again in Brazil.
|
5
|
Resverlogix Corp.
|
Jan 05, 2022 01:38PM
|
|
Re: A few thoughts
|
5
|
Resverlogix Corp.
|
Nov 16, 2019 07:17PM
|
|
Fun with Numbers
|
5
|
Resverlogix Corp.
|
Oct 18, 2022 11:13AM
|
